ArticleFrontiers in medicine2026

Impact of immunosuppressive therapy and clinical risk factors on the prevalence of low bone mineral density in rheumatic diseases.

Jan-Michael Brandt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.